Abbott India Ltd

Abbott India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Abbott India Ltd

₹ 26,543 0.50%
16 May - close price
abbott.co.in BSE: 500488 NSE: ABBOTINDIA
About

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.[1] It was established in 1944.[2]

Key Points

Abbott Group
The company is a part of Abbott Laboratories. The group has a presence in 160+ countries across the globe with a legacy of 130+ years.[1] [2]

Website BSE NSE
  • Market Cap ₹ 56,403 Cr.
  • Current Price ₹ 26,543
  • High / Low ₹ 29,639 / 20,594
  • Stock P/E 47.0
  • Book Value ₹ 1,741
  • Dividend Yield 0.68 %
  • ROCE 46.0 %
  • ROE 34.9 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 22.0% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 32.2%
  • Company has been maintaining a healthy dividend payout of 72.8%

Cons

  • Stock is trading at 15.2 times its book value
  • The company has delivered a poor sales growth of 9.72% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
1,096 1,218 1,222 1,224 1,255 1,304 1,379 1,322 1,343 1,479 1,494 1,437 1,439
890 953 962 955 961 1,034 1,036 1,010 1,063 1,124 1,113 1,049 1,109
Operating Profit 206 265 260 269 294 270 343 312 280 355 381 388 330
OPM % 19% 22% 21% 22% 23% 21% 25% 24% 21% 24% 25% 27% 23%
16 19 18 19 21 27 34 44 50 56 56 56 81
Interest 5 5 5 4 5 4 4 4 4 3 3 3 3
Depreciation 15 16 16 17 17 17 17 18 17 17 18 18 18
Profit before tax 202 264 257 267 292 275 355 335 308 390 415 422 390
Tax % 24% 26% 25% 25% 28% 25% 25% 26% 25% 26% 25% 26% 26%
152 196 192 199 211 206 266 247 231 290 313 311 287
EPS in Rs 71.75 92.13 90.51 93.74 99.49 96.77 124.95 116.16 108.91 136.59 147.27 146.35 135.09
Raw PDF

Profit & Loss

Figures in Rs. Crores

Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1,653 2,276 2,289 2,614 2,903 3,298 3,679 4,093 4,310 4,913 5,349 5,849
1,451 2,009 1,977 2,250 2,505 2,774 3,074 3,336 3,388 3,832 4,143 4,396
Operating Profit 202 267 312 365 398 525 605 757 922 1,082 1,206 1,453
OPM % 12% 12% 14% 14% 14% 16% 16% 18% 21% 22% 23% 25%
33 49 48 50 57 117 113 114 81 83 154 248
Interest 0 0 0 3 2 4 2 9 18 19 16 12
Depreciation 19 22 15 14 16 16 17 60 58 66 70 71
Profit before tax 215 295 344 398 436 621 699 803 926 1,080 1,274 1,618
Tax % 33% 33% 34% 36% 37% 35% 36% 26% 25% 26% 25% 26%
145 198 229 255 277 401 450 593 691 799 949 1,201
EPS in Rs 68.10 93.39 107.75 120.12 130.19 188.82 211.93 279.04 325.04 375.87 446.80 565.30
Dividend Payout % 25% 25% 29% 29% 31% 29% 31% 90% 85% 73% 73% 73%
Compounded Sales Growth
10 Years: 10%
5 Years: 10%
3 Years: 11%
TTM: 9%
Compounded Profit Growth
10 Years: 20%
5 Years: 22%
3 Years: 20%
TTM: 27%
Stock Price CAGR
10 Years: 31%
5 Years: 29%
3 Years: 18%
1 Year: 27%
Return on Equity
10 Years: 28%
5 Years: 30%
3 Years: 32%
Last Year: 35%

Balance Sheet

Figures in Rs. Crores

Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 21 21 21 21 21 21 21 21 21 21 21 21
Reserves 626 767 916 1,174 1,366 1,672 1,987 2,410 2,581 2,799 3,167 3,678
0 0 0 0 0 0 0 175 153 152 113 83
260 351 436 421 679 723 932 940 1,086 1,253 1,254 1,411
Total Liabilities 907 1,139 1,374 1,616 2,066 2,416 2,941 3,547 3,840 4,224 4,556 5,193
109 98 96 108 110 81 105 270 251 271 237 225
CWIP 1 1 4 3 6 2 1 2 1 1 4 10
Investments 0 0 0 0 0 0 0 0 0 0 0 0
798 1,040 1,274 1,505 1,950 2,333 2,835 3,275 3,589 3,952 4,315 4,958
Total Assets 907 1,139 1,374 1,616 2,066 2,416 2,941 3,547 3,840 4,224 4,556 5,193

Cash Flows

Figures in Rs. Crores

Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
101 155 215 249 307 153 499 626 727 948 893 1,213
-59 -144 -187 -77 -155 -215 -257 -401 -72 -396 -148 -416
-42 -42 -58 -80 -90 -102 -143 -217 -582 -637 -639 -745
Net Cash Flow 1 -31 -30 91 62 -165 99 8 73 -86 107 52

Ratios

Figures in Rs. Crores

Dec 2012 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 31 18 21 20 22 29 27 28 21 21 22 20
Inventory Days 99 101 107 91 107 112 106 83 110 94 80 70
Days Payable 38 38 54 56 101 92 116 104 116 122 109 114
Cash Conversion Cycle 92 80 74 54 28 49 17 8 14 -6 -8 -24
Working Capital Days 49 36 30 32 21 63 22 14 7 -4 -5 -12
ROCE % 34% 39% 40% 38% 34% 41% 37% 35% 35% 38% 41%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99%
0.25% 0.24% 0.22% 0.22% 0.20% 0.20% 0.20% 0.19% 0.19% 0.19% 0.18% 0.18%
6.74% 6.88% 6.76% 7.52% 7.95% 7.85% 8.38% 8.61% 8.77% 8.83% 8.73% 8.91%
18.03% 17.89% 18.04% 17.27% 16.86% 16.95% 16.42% 16.20% 16.05% 16.01% 16.09% 15.92%
No. of Shareholders 75,54073,41783,23690,56782,11383,52674,91572,08669,58268,88572,25269,382

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls